Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of dupilumab on sleep disturbance in uncontrolled persistent asthma
2020-001217-20Phase 4Completed
- Sponsor
- Sanofi
- Start
- Jul 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in asthma comparing Dupilumab with Placebo (2 arms). Primary endpoint: Change in Asthma Sleep Disturbance Questionnaire score. Started Jul 2020; status: completed.
02
Drugs
03
Conditions
asthma
Beyond the preview
Go deeper on 2020-001217-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001217-20.